FLOW CYTOMETRY, CD 1A

The Flow Cytometry CD1a Test is a specialized immunophenotyping assay used to detect and measure the expression of CD1a, a cell surface glycoprotein found on specific immune cells. CD1a is commonly expressed on cortical thymocytes, Langerhans cells, dendritic cells, and certain immature T-lymphocyte populations. It serves as an important diagnostic marker in hematology and pathology.

Flow cytometry enables rapid identification and analysis of CD1a-positive cells by examining thousands of cells individually within a sample. The test is widely used in the evaluation of acute leukemias, particularly T-cell Acute Lymphoblastic Leukemia (T-ALL), and in the investigation of Langerhans Cell Histiocytosis (LCH) and other immune-related disorders.

CD1a analysis is usually performed as part of a comprehensive immunophenotyping panel that includes multiple markers. The combined interpretation of these markers helps classify abnormal cell populations, establish an accurate diagnosis, and guide treatment decisions.

Benefits of the Test

• Detects CD1a-positive cell populations
• Assists in leukemia diagnosis and classification
• Supports evaluation of T-cell precursor disorders
• Helps identify Langerhans cell disorders
• Provides valuable immunophenotypic information
• Assists clinicians in treatment planning and monitoring

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD1a testing for:

• Suspected T-cell Acute Lymphoblastic Leukemia (T-ALL)
• Leukemia immunophenotyping
• Langerhans Cell Histiocytosis evaluation
• Bone marrow disorder investigation
• Abnormal lymphoid cell assessment
• Hematological malignancy workup
• Monitoring disease progression or treatment response
• Comprehensive flow cytometry analysis

The test helps determine whether abnormal cells express CD1a and assists in disease classification.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Tissue specimen
• Body fluid specimen
• Other clinically relevant samples

Preparation generally includes:

• No fasting is required
• Inform your doctor about current treatments
• Follow laboratory collection instructions

The sample is processed using advanced flow cytometry techniques in a specialized laboratory.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on panel complexity and laboratory workflow.

Who Should Take This Test?

• Patients with suspected leukemia
• Individuals undergoing immunophenotyping studies
• Patients with suspected Langerhans Cell Histiocytosis
• Individuals with abnormal blood or bone marrow findings
• Patients requiring hematological evaluation
• Individuals referred by hematologists or oncologists

Flow Cytometry CD1a testing is an important diagnostic tool in hematology and immunology.

Clinical Significance

CD1a expression may be associated with:

• T-cell Acute Lymphoblastic Leukemia (T-ALL)
• Cortical T-cell Leukemia/Lymphoma
• Langerhans Cell Histiocytosis (LCH)
• Dendritic Cell Disorders
• Immature T-cell Populations
• Certain Hematological Malignancies

Abnormal CD1a-positive cell populations may provide important diagnostic information and help differentiate between various hematological and immune-related conditions.

Important Note

CD1a is rarely interpreted as an isolated marker. It is typically evaluated alongside markers such as CD3, CD4, CD5, CD7, CD8, CD34, TdT, HLA-DR, and CD45 to establish a complete immunophenotypic profile and ensure accurate diagnosis.